ANGO stock news

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05), a pilot study to evaluate the safety and efficacy of the Company’s AURYON Atherectomy System in the treatment of de novo, re-stenotic, and in-stent restenosis (ISR) lesions in infrainguinal arte Read more
AngioDynamics (ANGO) retains fiscal 2020 view; VA revenues soft in fiscal Q2. Read more
ANGO earnings call for the period ending December 31, 2019. Read more

AngioDynamics out with Earnings

02:56pm, Tuesday, 07'th Jan 2020
AngioDynamics, Inc. (NASDAQ:ANGO) stocks trundled lower Tuesday on reports of its latest quarterly release. The company, based in Latham, New York, is a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral … Read more
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the second quarter of fiscal year 2020, which ended November 30, 2019. “Sales growth of 2.5%, ex-Asclera, exhibited continued momentum during the quarter, and I am pleased with the resulting gross margin expansion and profitability,” commented Jim Clemmer, Pres Read more

Earnings Scheduled For January 7, 2020

09:16am, Tuesday, 07'th Jan 2020
Companies Reporting Before The Bell Northern Technologies International Corporation (NASDAQ: NTIC ) is expected to report quarterly earnings at $0.13 per share on revenue of $15.00 million. AngioDynamics, Inc. (NASDAQ: ANGO ) is projected to report quarterly earnings at $0.02 per share on revenue of $71.28 … Full story available on Benzinga.com Read more

5 Stocks To Watch For January 7, 2020

09:14am, Tuesday, 07'th Jan 2020
Some of the stocks that may grab investor focus today are: Wall Street expects AngioDynamics, Inc. (NASDAQ: ANGO ) to report quarterly earnings at $0.02 per share on revenue of $71.28 million before the opening bell. AngioDynamics shares gained 3.4% to $17.48 in after-hours trading. Intra-Cellular Therapies Inc (NASDAQ: ITCI ) reported a proposed public offering of 10,000,000 shares of common stock. Intra-Cellular Therapies shares dropped 3.5% to $29.55 in the after-hours trading session. Analysts expect Northern Technologies International Corporation (NASDAQ: NTIC ) to report quarterly earnings at $0.13 per share on revenue of … Full story available on Benzinga.com Read more
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Sr. Vice President, General Counsel, and Interim Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 8:00 a.m. PT on Thursday, January 16, 2020 in San Francisco Read more
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2020 before the market open on Tuesday, January 7, 2020. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results. To participate in the conference call, dial Read more
AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical. Read more
AngioDynamics (ANGO) keeps fiscal 2020 revenue guidance intact, slashes EPS view. Read more
Q1 2020 AngioDynamics Inc Earnings Call Read more
AngioDynamics (ANGO) delivered earnings and revenue surprises of 100.00% and -2.32%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT